These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
486 related items for PubMed ID: 32820252
1. LncRNA KTN1-AS1 promotes the progression of non-small cell lung cancer via sponging of miR-130a-5p and activation of PDPK1. Li C, Zhao W, Pan X, Li X, Yan F, Liu S, Feng J, Lu J. Oncogene; 2020 Sep; 39(39):6157-6171. PubMed ID: 32820252 [Abstract] [Full Text] [Related]
2. STAT1-induced upregulation of lncRNA KTN1-AS1 predicts poor prognosis and facilitates non-small cell lung cancer progression via miR-23b/DEPDC1 axis. Liu C, Li X, Hao Y, Wang F, Cheng Z, Geng H, Geng D. Aging (Albany NY); 2020 May 12; 12(9):8680-8701. PubMed ID: 32396871 [Abstract] [Full Text] [Related]
3. lncRNA HNF1A-AS1 modulates non-small cell lung cancer progression by targeting miR-149-5p/Cdk6. Liu L, Chen Y, Li Q, Duan P. J Cell Biochem; 2019 Nov 12; 120(11):18736-18750. PubMed ID: 31243821 [Abstract] [Full Text] [Related]
4. LncRNA MAFG-AS1 facilitates the migration and invasion of NSCLC cell via sponging miR-339-5p from MMP15. Jia YC, Wang JY, Liu YY, Li B, Guo H, Zang AM. Cell Biol Int; 2019 Apr 12; 43(4):384-393. PubMed ID: 30599080 [Abstract] [Full Text] [Related]
5. [Overexpression of lncRNA FEZF1-AS1 promotes progression of non-small cell lung cancer via the miR-130a-5p/CCND1 axis]. Li F, Xiang J, Liu J, Wang X, Jiang H. Nan Fang Yi Ke Da Xue Xue Bao; 2024 May 20; 44(5):841-850. PubMed ID: 38862441 [Abstract] [Full Text] [Related]
6. Elevation of FGD5-AS1 contributes to cell progression by improving cisplatin resistance against non-small cell lung cancer cells through regulating miR-140-5p/WEE1 axis. Fu J, Cai H, Wu Y, Fang S, Wang D. Gene; 2020 Sep 10; 755():144886. PubMed ID: 32534055 [Abstract] [Full Text] [Related]
7. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis. He W, Zhang Y, Xia S. Thorac Cancer; 2020 Mar 10; 11(3):549-560. PubMed ID: 31923353 [Abstract] [Full Text] [Related]
8. LncRNA FAS-AS1 inhibits the progression of non-small cell lung cancer through regulating miR-19a-5p. Yang CB, Xiao SW, Cheng SM, Zhang C. Eur Rev Med Pharmacol Sci; 2020 Apr 10; 24(7):3775-3785. PubMed ID: 32329854 [Abstract] [Full Text] [Related]
9. Long non-coding RNA SLCO4A1-AS1 drives the progression of non-small-cell lung cancer by modulating miR-223-3p/IKKα/NF-κB signaling. Li Q, Jiang B, Qi Y, Zhang H, Ma H. Cancer Biol Ther; 2020 Sep 01; 21(9):806-814. PubMed ID: 32687454 [Abstract] [Full Text] [Related]
10. KLF5-induced BBOX1-AS1 contributes to cell malignant phenotypes in non-small cell lung cancer via sponging miR-27a-5p to up-regulate MELK and activate FAK signaling pathway. Shi J, Yang C, An J, Hao D, Liu C, Liu J, Sun J, Jiang J. J Exp Clin Cancer Res; 2021 Apr 30; 40(1):148. PubMed ID: 33931086 [Abstract] [Full Text] [Related]
11. LncRNA KTN1-AS1 promotes tumor growth of hepatocellular carcinoma by targeting miR-23c/ERBB2IP axis. Zhang L, Wang L, Wang Y, Chen T, Liu R, Yang W, Liu Q, Tu K. Biomed Pharmacother; 2019 Jan 30; 109():1140-1147. PubMed ID: 30551364 [Abstract] [Full Text] [Related]
12. PRKCZ-AS1 promotes the tumorigenesis of lung adenocarcinoma via sponging miR-766-5p to modulate MAPK1. Wang M, Liao Q, Zou P. Cancer Biol Ther; 2020 Apr 02; 21(4):364-371. PubMed ID: 31939714 [Abstract] [Full Text] [Related]
13. LncRNA SBF2-AS1 affects the radiosensitivity of non-small cell lung cancer via modulating microRNA-302a/MBNL3 axis. Yu Z, Wang G, Zhang C, Liu Y, Chen W, Wang H, Liu H. Cell Cycle; 2020 Feb 02; 19(3):300-316. PubMed ID: 31928130 [Abstract] [Full Text] [Related]
14. LncRNA NCK1-AS1 promotes non-small cell lung cancer progression via regulating miR-512-5p/p21 axis. Luo X, Zhou J, Quan L, Liang Y, Huang P, Chen F, Liu S. Pathol Res Pract; 2020 Nov 02; 216(11):153157. PubMed ID: 32858372 [Abstract] [Full Text] [Related]
15. LncRNA KTN1-AS1 facilitates esophageal squamous cell carcinoma progression via miR-885-5p/STRN3 axis. Chen L, Lu J, Li X, Wang X, Qiao R, Guo W, Ren Q. Genes Genomics; 2024 Feb 02; 46(2):241-252. PubMed ID: 37747640 [Abstract] [Full Text] [Related]
16. Long noncoding RNA DNAH17-AS1 promotes tumorigenesis and metastasis of non-small cell lung cancer via regulating miR-877-5p/CCNA2 pathway. Du LJ, Mao LJ, Jing RJ. Biochem Biophys Res Commun; 2020 Dec 10; 533(3):565-572. PubMed ID: 32981678 [Abstract] [Full Text] [Related]
17. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer. Huang Y, Ni R, Wang J, Liu Y. Biomed Pharmacother; 2019 Jan 10; 109():1851-1859. PubMed ID: 30551440 [Abstract] [Full Text] [Related]
18. Long noncoding RNA KTN1 antisense RNA 1exerts an oncogenic function in lung adenocarcinoma by regulating DEP domain containing 1 expression via activating epithelial-mesenchymal transition. Li YY, Li W, Chang GZ, Li YM. Anticancer Drugs; 2021 Jun 01; 32(6):614-625. PubMed ID: 33491970 [Abstract] [Full Text] [Related]
19. Silencing of Long Non-Coding RNA FGD5-AS1 Inhibits the Progression of Non-Small Cell Lung Cancer by Regulating the miR-493-5p/DDX5 Axis. Cui F, Luo P, Bai Y, Meng J. Technol Cancer Res Treat; 2021 Jun 01; 20():1533033821990007. PubMed ID: 33550957 [Abstract] [Full Text] [Related]
20. Down-regulation of MBNL1-AS1 contributes to tumorigenesis of NSCLC via sponging miR-135a-5p. Cao G, Tan B, Wei S, Shen W, Wang X, Chu Y, Rong T, Gao C. Biomed Pharmacother; 2020 May 01; 125():109856. PubMed ID: 32092823 [Abstract] [Full Text] [Related] Page: [Next] [New Search]